Intervention Insights
Waltham, US · Delaware corporation · 2 known investors
Healthtech
Founders & leadership
JM
JANINE MORALESNamed on SEC filing
RI
RUSSELL INGERSOLLNamed on SEC filing
EH
EPHRAIM HOCHBERGNamed on SEC filing
CT
CLYNT TAYLORNamed on SEC filing
MO
MARK OLESNAVAGENamed on SEC filing
MG
MICHAEL GROSSNamed on SEC filing
Board
WS
CC
Investors · 2
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 1 round · 2017
▶$4.2MraisedNov 2017 · 4 investors · Other Health CareRule 506(b)
▶$4.2MraisedNov 2017 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- WRIGHT STEENRODDirector
- JANINE MORALESExecutive Officer
- RUSSELL INGERSOLLExecutive Officer
- EPHRAIM HOCHBERGExecutive Officer
- CLYNT TAYLORExecutive Officer, Director
- CHARLIE CRAWFORDDirector
- MARK OLESNAVAGEDirector
- MICHAEL GROSSDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- Minimum investment
- $1K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Intervention Insights's investors?
- Intervention Insights's investors include WMU Biosciences Research & Commercialization Center, Chrysalis Ventures.
- How much funding has Intervention Insights raised?
- Intervention Insights has disclosed $4.2M raised across 1 round.
- Where is Intervention Insights headquartered?
- Intervention Insights is headquartered in Waltham, US.